Fessler et al.: ‘Curcumin Confers Anti-Inflammatory Effects in Adults Who Recovered from COVID-19 & Were Subsequently Vaccinated: A Randomized Controlled Trial’; as an anti-inflammatory, antioxidant

People are angry they took the failed deadly mandated COVID mRNA technology gene shots & want the spike (from virus or vaccine) out of them & they have post shot symptoms: they want help

SOURCE:
https://www.mdpi.com/2072-6643/15/7/1548

Alexander COVID News-Dr. Paul Elias Alexander’s Newsletter is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

‘curcumin, a polyphenolic compound derived from the rhizomes of turmeric (Curcuma Longa), providing the spices’ yellow pigment, has been recognized for its anti-inflammatory, antioxidant, anti-viral, and immune modulating properties’.

Start here:
‘This study was designed to examine the effects of curcumin supplementation, specifically HydroCurc (CURC), versus placebo (CON) on circulating inflammatory biomarkers in adults who had previously been diagnosed with COVID-19 and subsequently received a primary series of monovalent vaccine doses.
This study was conducted between June 2021 and May 2022. Participants were randomized to receive CURC (500 mg) or CON capsules twice daily for four weeks. Blood sampling was completed at baseline and week-4 and analyzed for biomarkers.
Linear regression was utilized to examine the between-group differences in post-trial inflammatory biomarker levels, adjusting for baseline and covariates including age, sex, race/ethnicity, and interval between COVID-19 diagnosis and trial enrollment.
The sample (n = 31) was 71% female (Age 27.6 ± 10.4 y). The CURC group exhibited significantly lower post-trial concentrations of proinflammatory IL-6 (β = −0.52, 95%CI: −1.03, −0.014, p = 0.046) and MCP-1 (β = −0.12, 95%CI: −0.23, −0.015, p = 0.027) compared to CON, adjusting for baseline and covariates.

Curcumin intake confers anti-inflammatory activity and may be a promising prophylactic nutraceutical strategy for COVID-19. These results suggest that 4 weeks of curcumin supplementation resulted in significantly lower concentrations of proinflammatory cytokines in adults who recovered from COVID-19 infection and were subsequently vaccinated.’

McCullough’s superb substack on the issue and I read his work and decided to write my own review of this study and the implications (thank you Dr. McCullough for your fine work and mentorship):

Courageous Discourse™ with Dr. Peter McCullough & John Leake

Curcumin Confers Anti-Inflammatory Effects in Adults Who Recovered from COVID-19 and Were Subsequently Vaccinated: A Randomized Controlled Trial

By Peter A. McCullough Approximately two thirds of the world’s population have taken a COVID-19 vaccine, and now most regret it. In countries like Australia, the population was vaccinated first and then most became COVID-19 vaccine failures by contracting the SARS-CoV-2 infection. In the US, many contracted the virus first in 2020 and 2021 and later…
Read more
2 days ago · 115 likes · 12 comments · Peter A. McCullough, MD, MPH™

Alexander COVID News-Dr. Paul Elias Alexander’s Newsletter is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Go to Dr Alexancer on Substack
Author: Dr. Paul Alexander